Acer Therapeutics Inc (NASDAQ:ACER)

19.38
Delayed Data
As of 2:14pm ET
 +0.64 / +3.42%
Today’s Change
5.70
Today|||52-Week Range
22.63
+39.93%
Year-to-Date

Today’s Trading

Previous close18.74
Today’s open19.07
Day’s range19.07 - 19.86
Volume5,309
Average volume (3 months)16,073
Market cap$137.8M
Data as of 2:14pm ET, 06/19/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+16.15%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book6.17

Competitors

 Today’s
change
Today’s
% change
EVFMEvofem Biosciences I...-0.01-0.29%
--Achieve Life Science...-0.14-3.85%
MBVXMabVax Therapeutics ...+0.03+3.37%
CPHIChina Pharma Holding...-0.02-6.48%
Data as of 2:27pm ET, 06/19/2018

Financials

Next reporting dateAugust 13, 2018
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$0.00
Annual profit (last year)-$14.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Christopher Schelling
Chief Financial Officer
Harry S. Palmin
Corporate headquarters
Newton, Massachusetts

Forecasts